Madden James C. 4

What Happened

• James C. Madden, a director of Genpact Ltd. (G), was granted 9,999 restricted stock units (RSUs) on April 23, 2026. The award is reported as an "A" (award/grant) transaction at $0.00 per RSU (aggregate $0).
• This grant is an equity compensation award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-23. Form 4 filed: 2026-04-27 (Accession No. 0001408228-26-000002).
• Transaction type/code: Award/Grant (A). Amount: 9,999 RSUs; reported price: $0.00; aggregate value reported: $0.
• Vesting/settlement (per footnote F1): RSUs will fully vest on December 31, 2026, subject to continued service, and will be settled in common shares on December 31, 2027. Grant made under the Genpact Limited 2017 Omnibus Incentive Compensation Plan.
• Shares owned after transaction: not specified in the provided filing details.
• Filing timeliness: Filing occurred four days after the transaction date; this appears later than the typical two-business-day Form 4 filing requirement.

Context

• RSUs are deferred equity awards that convert to shares at vesting/settlement; this grant represents compensation for service rather than a buy or sell signal. It does not indicate an immediate cash inflow or open-market trading by the director.
• For retail investors: awards like this are common for directors and executives as part of compensation. They are informative about long-term alignment but should not be interpreted alone as a directional bet on the stock.